First new Alzheimer’s drugs in 20 years to bring hope for early-stage patients

ADNeT Director Professor Chris Rowe and Chief Investigator Ralph Martins both expressed optimism in the potential for new disease modifying drugs expected to be approved for clinical use in Australia this year. They were interviewed for The Age, Brisbane Times and Channel 7.

Read the article here.  

Watch the news segment here.

The ADRF2024 was mentioned in the Riverine Herald, covering the great work being undertaken by Professor Sharon Naismith with the launch of a Virtual Memory Clinic in Echuca. Read more here.